PATENT CLAIM ANALYSIS

Application Number: 16005228
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "006140"]

Abstract:
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.

Claim (Index 32):
The method of  claim 30 , which comprises detecting two or more of (i) a copy number gain of the CMYC gene that is greater than 2, (ii) duplication of an ERG gene fusion and an interstitial deletion of sequences 5\u2032 to the ERG gene (ERG 2+Edel), and/or (iii) a copy number loss of the FGR1 gene that is less than 1.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.73171
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14788195', '13721081', '15443499', '14207682', '13721076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6822318853124125
- 35 USC 102 Novelty (BERT): 0.5627192307427918
- Combined Prediction Score: 0.6702806198554505
- Mean Citation Score: 403.382844
- Max Citation Score: 625.5991
- Similarity Product: 317.92680874472865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test